Skip to main content
Emily Sims, MD, Pediatric Endocrinology, Indianapolis, IN, Indiana University Health North Hospital

EmilyKristenSimsMD

Pediatric Endocrinology • Indianapolis, IN

Associate Professor of Pediatrics at Indiana University School of Medicine

Join to view full profile

Dr. Sims is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Sims' full profile

Already have an account?

Summary

  • Dr. Emily K. Sims MD, MS is a physician scientist specializing in pediatric endocrinology, with a long-term goal of addressing clinically relevant problems in diabetes utilizing molecular discovery. Her research focus revolves around the investigation of molecular mechanisms contributing to β cell dysfunction and the development of diabetes, the identification and verification of circulating biomarkers of β cell dysfunction, and clinical studies identifying and targeting β cell dysfunction in T1D. She hopes to ultimately utilize knowledge gained for development of biomarkers and β cell-targeted therapeutics that allow for a more tailored approach to treatment of patients with or at-risk for diabetes.

Education & Training

  • Indiana University School of Medicine
    Indiana University School of MedicineFellowship, Pediatric Endocrinology, 2013
  • University of Alabama School of Medicine
    University of Alabama School of MedicineClass of 2007

Certifications & Licensure

  • IN State Medical License
    IN State Medical License 2010 - 2025
  • American Board of Pediatrics Pediatrics
  • American Board of Pediatrics Pediatric Endocrinology

Publications & Presentations

PubMed

Press Mentions

  • Type 1 Diabetes: Recent Wins and Ongoing Challenges on the Road to a Cure
    Type 1 Diabetes: Recent Wins and Ongoing Challenges on the Road to a CureMay 24th, 2023
  • IU Research Contributes to First FDA-approved Drug to Delay Onset of Type 1 Diabetes
    IU Research Contributes to First FDA-approved Drug to Delay Onset of Type 1 DiabetesNovember 21st, 2022
  • FDA Approves First-Ever Agent to Delay Type 1 Diabetes Onset
    FDA Approves First-Ever Agent to Delay Type 1 Diabetes OnsetNovember 18th, 2022
  • Join now to see all

Hospital Affiliations

Dr. Emily Sims, Dr. Emily Sims, MD, Dr. E Sims, Dr. Emily Kristen Sims